ResultsIQ

ResultsIQ › Latest results › Tata Chemicals Limited

Tata Chemicals Limited Q4 FY26 results deck summary

NSE: TATACHEM · BSE: 500770

Results deck of 4 May 2026, summarised by AI from the filing.

US impairment charge of ₹ 1,837 cr on goodwill and ₹ 182 cr deferred tax assets write off recognised amidst soda ash market conditions.

Key takeaways

  1. Impairment US impairment charge of ₹ 1,837 cr on goodwill and ₹ 182 cr deferred tax assets write off recognised amidst soda ash market conditions.
  2. Non-soda ash Non-soda ash revenue grew 14% from ₹ 6,118 cr in FY25 to ₹ 6,946 cr in FY26, in line with focus to grow non-cyclical business.
  3. Debt Net debt (external) rose to ₹ 5,961 cr at Mar 26 from ₹ 4,884 cr at Mar 25, on lower cash generation and ₹ 460 cr forex impact.

Original filing on BSE

Tata Chemicals Limited Q1 FY27 results

As filed: Revenue ₹4,255 cr (+14% year on year), EBITDA ₹555 cr (−14% year on year), PAT ₹60.0 cr (−81% year on year), EBITDA margin 13.0% (−441 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹3,438 cr (−2% year on year), EBITDA ₹274 cr (−16% year on year), PAT −₹2,116 cr, EBITDA margin 8.0% (−135 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 135 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: −1.7%).
  • Q3 FY26: Revenue ₹3,550 cr (−1% year on year), EBITDA ₹345 cr (−21% year on year), PAT −₹69.0 cr (−265% year on year), EBITDA margin 9.7% (−237 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit before exceptional items growth was well below it. EBITDA margin fell 237 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −2.6% in 30 days (Nifty 500: −1.9%).
  • Q2 FY26: Revenue ₹3,877 cr (−3% year on year), EBITDA ₹537 cr (−13% year on year), PAT ₹154 cr (−19% year on year), EBITDA margin 13.9% (−160 bps). Score 27 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin fell 160 bps year on year. Other income 76% of PBT. Tax rate 45%. Consolidated profit -42% but standalone +80%. Profit fell 23% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: +0.9%).
  • Q1 FY26: Revenue ₹3,719 cr (−2% year on year), EBITDA ₹649 cr (+13% year on year), PAT ₹316 cr (+66% year on year), EBITDA margin 17.5% (+230 bps). Score 54 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 230 bps year on year. Other income 30% of PBT. Tax rate 14%. Share price after the results: −0.4% in 28 days (Nifty 500: −0.1%).
  • Q4 FY25: Revenue ₹3,509 cr (+1% year on year), EBITDA ₹327 cr (−26% year on year), PAT −₹49.0 cr (−139% year on year), EBITDA margin 9.3% (−343 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 343 bps year on year. Profit fell 279% from last quarter. Share price after the results: +13.1% in 30 days (Nifty 500: +5.0%).
  • Q3 FY25: Revenue ₹3,590 cr (−4% year on year), EBITDA ₹434 cr (−20% year on year), PAT −₹21.0 cr (−83% year on year), EBITDA margin 12.1% (−244 bps). Score 32 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 244 bps year on year. Revenue fell 10% from last quarter.
  • Q2 FY25: Revenue ₹3,999 cr (0% year on year), EBITDA ₹618 cr (−25% year on year), PAT ₹267 cr (−46% year on year), EBITDA margin 15.5% (−503 bps). Score 5 of 100, Below trend. EBITDA margin fell 503 bps year on year. Other income 36% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Tata Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.